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Abstract This note is to report how histological prepara-
tion techniques influence the extravasation pattern of the
different molecular sizes of fluorescein isothiocyanate
(FITC)–dextrans, typically used as markers for blood-
brain barrier leakage. By using appropriate preparation
methods, false negative results can be minimized. Wistar
rats underwent a 2-h middle cerebral artery occlusion and
magnetic resonance imaging. After the last imaging scan,
Evans blue and FITC–dextrans of 4, 40, and 70 kDa
molecular weight were injected. Different histological
preparation methods were used. Sites of blood-brain barrier
leakage were analyzed by fluorescence microscopy. Ex-
travasation of Evans blue and high molecular FITC–
dextrans (40 and 70 kDa) in the infarcted region could be
detected with all preparation methods used. If exposed
directly to saline, the signal intensity of these FITC–
dextrans decreased. Extravasation of the 4-kDa low
molecular weight FITC–dextran could only be detected
using freshly frozen tissue sections. Preparations involving
paraformaldehyde and sucrose resulted in the 4-kDa FITC–
dextran dissolving in these reactants and being washed out,
giving the false negative result of no extravasation. FITC–
dextrans represent a valuable tool to characterize altered
blood-brain barrier permeability in animal models. Diffu-
sion and washout of low molecular weight FITC–dextran
can be avoided by direct immobilization through immediate
freezing of the tissue. This pitfall needs to be known to
avoid the false impression that there was no extravasation
of low molecular weight FITC–dextrans.
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Introduction
The blood-brain barrier (BBB), formed by the cerebral
microvascular endothelium, represents an essential compo-
nent together with supporting structures for the health and
function of the central nervous system. In several diseases,
including stroke, encephalitis, and brain tumors, the perme-
ability of the BBB is increased, and its loss of integrity may
reflect the severity or progression of a disease [1]. This is the
rationale for trying to quantify the blood-brain barrier
permeability (BBBP), using either in vivo imaging, such as
CTor MRI [2, 3] or microscopic tracers in animal models. In
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sacrificing the animal, and the fraction that extravasates is
considered as a biomarker of the BBBP.
Imaging or microscopic tracers can be classified into two
categories: indicators for solute and ion permeability and
indicators for protein permeability [4]. Also, because
disruption of the blood-brain barrier is not an “all-or-
nothing” phenomenon, the molecular size of the tracers
needs to be taken into consideration. Typically, several
probes of increasing molecular sizes are used to make
interferences about the magnitude of the BBB opening [5,
6]. If both the high and the low molecular weight tracers
extravasate, the BBBP is considered to increase more than
if only the low molecular weight tracers extravasate.
Gadolinium–DTPA (molecular weight, 552 Da) is typically
an imaging marker for solute and ion permeability while Evans
blue dye, which binds to albumin (molecularweight, ≈68 kDa),
is an imaging marker for protein permeability [4]. Fluorescein
isothiocyanate (FITC)–dextrans can be obtained in different
molecular sizes (molecular weights ranging from 3 kDa to
2,000 kDa) and have the additional advantage that, depending
on their molecular size, they can be used to test both solute
and ion permeability (low molecular weight dextrans) and
protein permeability (high molecular weight dextrans).
In a recent study, where we were trying to validate in vivo
permeability imaging using gadolinium–DTPA by comparison
with histological extravasation of Eb-Alb and FITC–dextrans
in a rat model of a 2-h middle cerebral artery occlusion, we
were surprised when we observed that low molecular weight
FITC–dextrans seemed to extravasate less than Eb-Alb despite
a smaller molecular size. A set of additional, dedicated
experiments revealed that this counterintuitive observation
was due to the histological preparation technique. More
specifically, when the standard histological preparation tech-
nique used for Eb-Alb and high molecular weight FITC–
dextrans was applied to the low molecular weight FITC–
dextrans, the latter got dissolved and eliminated from the
histological slides, giving the false impression that there was no
extravasation of low molecular weight FITC–dextrans.
The goal of this technical note is to report this pitfall and
the set of experiments that allowed to understand it so that
other groups in the future can avoid it when they are using
FITC–dextrans of variable molecular sizes to validate a new
in vivo imaging method to assess BBBP.
Material and Methods
Animal Preparation, Surgery, and Magnetic Resonance
Imaging
The experimental animals were cared for in accordance
with the Animal Welfare Act. The experimental protocol
was performed in compliance with our institutional guide-
lines for animal research and was approved by the
University of California San Francisco Committee on
Animal Research. All experiments—surgery, MR imaging,
and tracer injection—were conducted while the animals
were anesthetized. Anesthesia was induced by isoflorane
3.5% and then maintained at 2% using a face mask. Body
temperature was maintained at 37°C using a water-heated
circulating pad and monitored via an intrarectal thermo-
couple. Wistar rats (n=8) between 220 and 280 g were
subjected to a 2-h filament occlusion of the right middle
cerebral artery following published procedures [7]. Mag-
netic resonance imaging was performed with a 2T Bruker
Omega CSI system (Bruker, Fremont, California) equipped
with Acustar S-150 self-shielded gradients (±20 G/cm,
15 cm inner diameter). Diffusion and perfusion-weighted
magnetic resonance imaging using gadolinium–DTPA
(molecular weight, 552 Da) were obtained during occlu-
sion, as well as 4 and 24 h after reperfusion. Immediately
after the 24-h MRI scan, fluorescent tracers were adminis-
tered (times indicated in the next section).
Injection and Circulation Time of the Fluorescent Tracers
Three FITC–dextrans of different molecular sizes (molec-
ular weights; 4, 40, and 70 kDa) and Evans blue albumin
(molecular weight, ≈68 kDa) were used as gold standard for
the evaluation of BBBP. Immediately after the last MRI
scan, the animal was intravenously injected with Evans
blue (Sigma Chemical Co., St. Louis, MI, USA; 0.5 ml of a
2% solution in saline), which circulated for 30 min. After
28 min of Evans blue circulation, one of three FITC–
dextrans (Sigma Chemical Co., St. Louis, MI, USA; 0.5 ml
of a 100-mg/ml solution in saline of 40 and 70 kDa; 0.5 ml
of a 300-mg/ml solution in saline of 4 kDa) was
administered intravenously to circulate for 2 min. At the
end of the circulation period, the rats were killed by
decapitation, their brains were quickly removed.
A shorter circulation time of 2 min has been chosen for
the FITC–dextran tracer, as the tracer clears more rapidly
from the system than the Evans blue dye, which binds to
plasma albumin immediately after injection. Plasma pro-
teins have been shown not to bind to FITC–dextran.
Dextrans are mainly eliminated from the body by renal
excretion [8, 9] while Evans blue is mainly cleared from the
intravascular compartment by phagocytosis into the reticu-
loendothelial system. As a result, approximately 30–50% of
the initial plasma concentration of Evans blue-tagged
albumin is still found 24 h after injection [10].
In addition, a higher concentration for the low molecular
FITC–dextran was used. Indeed, the renal excretion rate of
dextrans is an inverse function of their molecular weight. It
follows biphasic clearance kinetics [9] with a significantly
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fraction with a molecular weight >50 kDa, which represents
the renal threshold.
Histological Tissue Preparation
The following four different fixation methods were tested
(Fig. 1):
1. Brains, which had been quickly removed after decap-
itation, were fixed by immersion in 4% paraformalde-
hyde (PFA) for 24 h, then kept 48 h in 30% sucrose for
dehydration. Afterwards, brains were embedded in
optimum cutting temperature (OCT) cryostat-
embedding compound (Tissue-Tek, Torrance, CA),
frozen on dry ice, cut into 50-μm thick sections on a
cryostat (Leica Microsystems, Wetzlar, Germany) at
−19°C, and mounted on gelatinized slides. The slides
were not allowed to thaw. Sections were washed by
covering them with saline for 30 s in order to dissolve
the OTC compound before being coverslipped. Sec-
tions were subsequently directly coverslipped with
Dapi mounting media (Vector, Burlingame, CA) and
analyzed on the microscope right afterwards.
2. Same as #1, but without saline washing. In order to
compare preparations #1 and #2, the same sections were
first coverslipped without washing. After being analyzed
on the microscope, the coverslip was removed, the slide
waswashedfor 30s bycoveringtheslideswithsaline,re-
coverslipped and analyzed on the microscope.
3. The brains were fixed by immersion in 4% paraformal-
dehyde for 24 h and afterwards snap frozen with liquid
nitrogen. Frozen brains were embedded in OCT
cryostat-embedding compound (Tissue-Tek, Torrance,
CA), cut into 50-μm thick sections on a cryostat (Leica
Microsystems, Germany) at −19°C, and mounted on
gelatinized slides. The slides were not allowed to thaw.
Brain sections were directly coverslipped with Dapi
mounting media (Vector, Burlingame, CA) and ana-
lyzed on the microscope right afterwards.
4. The brains were freshly frozen with 2-methylbutane on
dry ice. Frozen brains were embedded in OCT cryostat-
embedding compound (Tissue-Tek, Torrance, CA), cut
into 50-μm thick sections on a cryostat (Leica Micro-
systems, Germany) at −19°C, and mounted on gelati-
nized slides. The slides were not allowed to thaw. Brain
sections were directly coverslipped with Dapi mounting
media (Vector, Burlingame, CA) and analyzed on the
microscope right afterwards.
Microscopy
The brain sections were visualized using a fluorescent
microscope and standard filter set. Adjacent sections were
stained with cresyl violet in order to delineate the infarcted
area. On the cresyl violet sections, the infarct core was
identified on light microscopy as a region of pallor that
contained shrunken cell bodies characteristic of neuronal
cell death.
Extravasation of the FITC–dextran was determined as
clear specific fluorescence occurring outside the vessel
lumina. Vascular leakage of the Evans blue-tagged albumin
represented two different patterns, extravasated tracer
outside the vessel lumina and cellular uptake. Extravasation
was classified as weak (+), medium (++), strong (+++), and
diffuse (++++) extravasation, and the extravasation profile
of free tracers was characterized. Weak extravasation was
defined as a faint cloud, clearly associated with one vessel
site of the tracer leakage. Medium extravasation was
defined as a bright cloud, clearly associated with one
vessel site of the tracer leakage. Strong extravasation was
defined as a bright cloud, not clearly associated with one-
vessel leakage, but a group of vessels. Diffuse extravasation
was defined as extensive leakage of the tracer without clear
association of specific vessels.
Fig. 1 Four different fixation methods that were tested
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All animals showed a complete middle cerebral artery
occlusion on the diffusion-weighted images during occlu-
sion and no blood flow in the middle cerebral artery
territory on the perfusion-weighted images.
Using preparation methods #1 and #2, tracer leakage was
detected in the infract core in all animals which had been
injected with the 40 and the 70-kDa dextran. Including a 30-s
washing step (preparation #2) resulted in a decrease of the
intensity of the FITC–dextran extravasation. (Table 1;F i g .2)
Animals, which had been injected with the 4-kDa
dextran did not show any apparent leakage of FITC–
dextran if fixed by immersion in paraformaldehyde and
sucrose (preparations #1 and #2) or just in paraformalde-
hyde (preparation #3). Interestingly, for all preparations,
4 kDa dextran could be identified within the lumen of the
vessels on the contralateral side to the ischemic lesions.
When freshly frozen sections were used (preparation #4),
leakage of the 4-kDa dextran could be visualized on the
infarcted ipsilateral side. Compared to the larger molecular
weight dextrans, the extravasated 4-kDa dextran tends to
spread out further away from the vessels into the
extravascular space (Table 2; Fig. 3).
Discussion
Our interpretation of our results was as follows: The
extravasation of FITC–dextrans in colliquative necrosis is
an inverse function of their molecular weight, and low
molecular weight FITC–dextrans always extravasate more
than high molecular weight FITC–dextrans. In addition,
dextrans are water soluble molecules, and their solubility
also depends on the molecular weight [11]. Smaller
dextrans are more soluble in PFA and in sucrose and more
readily washed out the slides when immersed in these
reactants. As a result, low molecular weight FITC–dextrans
are not detected on the slides when such histological
preparations are used. On the other hand, if brains are
Table 1 Apparent degree of extravasation of the different tracers used for preparation methods #1 and #2
EB-Alb 70 kDa dextran 40 kDa dextran 4 kDa dextran
Preparation #1 (PFA+sucrose+wash) Extravasation + Extravasation + Extravasation + No extravasation seen
Preparation #2 (PFA+sucrose) Extravasation + Extravasation ++ Extravasation ++ No extravasation seen
EB-Alb Evans blue dye, which binds to albumin
Fig. 2 A set of images showing the distribution of Evans blue-tagged
albumin and 70 kDa and 40 kDa FITC dextrans in the infarction core
after washing and without washing, in a region surrounding a vessel
where BBB opening occurred. The extravasated Evans blue albumin is
visible as a faint cloud around the vessel and also internalized in cells
around the vessel. a, d For both the 70 kDa and 40 kDa FITC
dextrans, a faint green cloud surrounds the lumen of the vessel after
the 30-s washing step. b, e If the section does not undergo washing
and is not exposed to saline—and therefore the FITC–dextran is not
dissolved—the cloud around the vessel lumen at the leakage site
appears much brighter. c, f A 20-μm space bar appears in f and holds
for all images
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other steps of the experiment are kept the same (type of
occlusion, duration of occlusion, and slide preparation), the
extravasation of low molecular weight FITC–dextrans can
be visualized and is seen to be more important than the
extravasation of high molecular weight FITC–dextrans.
Compared to the ischemic side the nonischemic side,
where the BBBP is not increased and the tissue structure
is intact, less extravasation of low molecular weight
FITC–dextrans from the intravascular to the extravascu-
lar compartment occurs. These dextrans can be visualized
within the vessels even when PFA and sucrose are used
for the histological preparation because most of the
dextran molecules never made it into the extravascular
space where they would have been washed by the PFA
or sucrose. This is in accordance with other studies,
which examined intact brain structure and detected
4 kDa dextran or NaFl using standard histologic
processing including PFA [12, 13].
Exposing the sliced brains with dextrans of any size to
fluid decreases the intensity of the visualized extravasation
of these dextrans, especially in colliquative necrosis which
occurs after ischemic infarction. Therefore, steps as
washing, processing methods like floating sections, further
EB-Alb 4 kDa dextran
Preparation #1 (PFA+sucrose+wash) Extravasation + No extravasation seen
Preparation #2 (PFA+sucrose) Extravasation + No extravasation seen
Preparation #3 (PFA+freezing) Extravasation + No extravasation seen
Preparation #4 (direct freezing) Extravasation ++ Extravasation ++++
Table 2 Apparent degree of
extravasation of the 4-kDa
FITC–dextran for all preparation
methods used
Fig. 3 Representing images showing the leakage pattern of Evans
blue-tagged albumin and of the 4-kDa FITC–dextran in the infarction
core after different histologic processing procedures on the sides
ipsilateral and contralateral to the infarct. On the ischemic side, the
extravasation of Evans blue-tagged albumin resulted in diffuse and a
punctuated distribution (cellular uptake) of the red fluorescence. a, e If
the brain was frozen directly, free Evans blue-tagged albumin was
more important. i On the nonischemic side, Evans blue-tagged
albumin remains in the vessel lumen. c, g, l The appearance of the
4-kDa FITC–dextran for the same fields depends upon the processing
method. On the ipsilateral side, using preparation #2 (PFA+sucrose)
and #3 (PFA+freezing), no leakage of 4 kDa FITC–dextran can be
detected. b, f If frozen directly, a bright green fluorescent cloud
diffuses out at the site of the BBB opening. k On the contralateral
side, 4 kDa FITC–dextran can be detected intravascularly when PFA+
sucrose (preparation #1) or only PFA are used (preparation #2). d, h A
20-μm space bar appears in m and holds for all the images
110 Transl. Stroke Res. (2011) 2:106–111examination of the tissue using antibody solutions, or any
kind of exposure to fluid should be used with caution.
FITC–dextrans represent a valuable tool to characterize the
BBB and quantify how much its permeability is altered/
increased in animal models. The use of low molecular weight
FITC–dextran for histological experiments, however, does
require special attention and modification of the standard
tissue preparation. Diffusion and washout of the tracer can be
avoided by direct immobilization through immediate freezing
of the tissue. This pitfall needs to be known to avoid the false
impression that there was no extravsation of low molecular
weight FITC–dextrans.
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